Neurodevelopmental Disorders: Mechanisms and Therapeutics

About This Grant

Abstract Support is requested for a Keystone Symposia conference entitled Neurodevelopmental Disorders: Mechanisms and Therapeutics, organized by Drs. Tomasz Nowakowski, Xin Jin, Stephan Sanders and Zhaolan (Joe) Zhou, with scientific programming input from Keystone Symposia. The meeting will take place January 19-22, 2027 at Beaver Run Conference Center, Breckenridge, CO. Neurodevelopmental disorders (NDDs), including autism, intellectual disability, and epilepsy, arise from disruptions during brain development and pose major challenges to public health. Although advances in genetics have identified hundreds of causal genetic risk factors, identifying convergent mechanisms underlying their pathobiology remains a challenge, which hinders the development of personalized therapies. This meeting addresses the critical gap between emerging insights into causal factors, neurodevelopment, and therapeutic innovation by uniting experts across basic and translational neuroscience. The proposed conference will foster new collaborations between investigators in genetics, functional genomics, developmental neurobiology, and industry. Specific aims include showcasing breakthroughs in single-cell genomics, genome perturbation technologies, gene-environment interactions, and novel therapeutic strategies such as gene replacement therapies and antisense oligonucleotides (ASOs). The program is designed to challenge prevailing hypotheses towards understanding NDDs by taking a holistic perspective on molecular, cellular, and circuit level mechanisms underlying brain development and their vulnerabilities to genetic and environmental risk factors for NDDs. By integrating state-of-the-art technologies into biologically driven sessions, the conference will emphasize translational pathways from discovery of causal risk factors to clinical impact. Attendees will gain exposure to innovative methodologies, mechanistic frameworks, and considerations for clinical trials, thereby advancing the field toward tangible treatments. Unlike existing meetings that focus separately on neurodevelopment, stem cell models or therapeutic pipelines, this conference uniquely fuses mechanistic understanding of genetic and environmental causes with translational application. Interactive sessions, panel discussions, and strong industry participation make this a pivotal forum for scientists seeking to shape the next generation of neurodevelopmental disorder research.